CL-ACP: a parallel combination of CNN and LSTM anticancer peptide recognition model

Background: Anticancer peptides are defence substances with innate immune functions that can selectively act on cancer cells without harming normal cells and many studies have been conducted to identify anticancer peptides. In this paper, we introduce the anticancer peptide secondary structures as a...

Full description

Bibliographic Details
Main Authors: Li, H. (Author), Wang, H. (Author), Wang, J. (Author), Zhao, H. (Author), Zhao, J. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2021
Subjects:
Online Access:View Fulltext in Publisher